Design and Synthesis of Porphyrins
J . Org. Chem., Vol. 66, No. 20, 2001 6521
6-(Dim eth oxym eth yl)u r a cil (9). A solution of orotalde-
hyde (8) (3.0 g, 21.42 mmol) and trimethyl orthoformate (9.08
g, 9.4 mL, 85.68 mmol) in MeOH (50 mL) and CH2Cl2 (100
mL) was refluxed for 10 h in the presence of p-toluenesulfonic
acid (0.3 g, 1.58 mmol). After the reaction mixture cooled to
room temperature, triethylamine was added to the reaction
mixture until it turned weakly basic. 5.0 g silica gel was added
to the reaction mixture and the solvent removed under reduced
pressure. The resultant yellow material was added to the top
of a 25 g column of silica gel and eluted with ethyl acetate/
ethanol (9:1) to afford 3.46 g (87%) of the acetal 9 as a white
powder, mp 185-186 °C, (lit.:22a 185-186 °C). 1H NMR (CDCl3)
δ 11.02 (br, s, 1H), 10.83 (br, s, 1H), 5.45 (s, 1H), 4.99 (s, 1H),
3.25, (s, 6H); 13C NMR (CDCl3) δ 164.9, 152.4, 151.8, 99.5, 99.1,
54.8; MS (ESI) m/z (M-H+, 185).
1-Bu tyl-6-(d im eth oxym eth yl)u r a cil (10). To a solution
of the acetal (9) (3.20 g, 17.20 mmol) in DMSO (200 mL) were
added 1-bromobutane (0.7850 g, 0.62 mL, 5.73 mmol) and
anhydrous K2CO3 (2.61 g, 18.92 mmol). The suspension was
stirred for 72 h at room temperature after which it was filtered
and the DMSO was removed in vacuo. The solid was absorbed
on 5 g silica gel, loaded on the top of a 25 g column of silica
gel, and eluted with hexane to afford 0.140 g (8.2%) of 1,3-
dibutyl-6-(dimethoxymethyl)uracil as an oil. Further elution
with ethyl acetate/hexane (1:9) afforded 0.222 g (16%) 3-butyl-
6-(dimethoxymethyl)uracil and 0.513 g (37%) of 10. Yields
reported for this compound are based on 1-bromobutane, mp:
91-92 °C. 1H NMR (CDCl3) δ 9.28 (br, s, 1H), 5.95 (s, 1H),
5.05 (s, 1H), 3.87 (t, 2H, J ) 7.7 Hz), 1.67-1.57, (m, 2H), 1.42-
1.30, (m, 2H), 0.95, (t, 3H, J ) 6.9 Hz); 13C NMR (CDCl3) δ
163.4, 152.2, 151.3, 102.7, 99.9, 54.5, 45.1, 31.7, 20.8, 14.5; MS
(ESI) m/z (MH+, 243).
pyrrole, the isolated yield is 20.6%, and the isolated amounts
are I, 0.153 g (3.5%); II, 0.261 g (5.14%); III, 0.222 g (4.11%);
IV, 0.290 g (5.36%); V, 0.149 g (2.60%); VI, 0.052 g (0.86%).
The relative amounts are II (24%), III (20%), IV (26%), and V
(11%), and the two homo-substituted porphyrins I (14.5%) and
VI (4.5%).
5-(3,5-Dia cet a m id o-4-p yr id yl)-10,15,20-t r is(4-ter t-b u -
tylp h en yl)p or p h yr in (II). 1H NMR (CDCl3) [500 MHz NMR,
50 °C] δ 9.11, 9.05 (d, 2H, J ) 5.0 Hz), 8.92 (s, 4H), 8.81 (s,
2H), 8.89 (s, 2H), 8.175, 7.785 (d, 12H, J ) 7.5 Hz), 2.298 (s,
6H), 1.637 (s, 27H), -2.761 (s, 2H); 13C NMR (DMSO-d6) δ
169.0, 156.1, 151.1, 148.4, 139.7, 135.1, 131.7-131.9, 124.2,
121.6, 121.2, 117.0, 35.7, 32.5, 25.6; MS (ESI) m/z (MH+, 898).
5,15-Bis(3,5-d ia ceta m id o-4-p yr id yl)-10,20-bis(4-ter t-bu -
tylp h en yl)p or p h yr in (III). 1H NMR (CDCl3) δ 9.27, 9.23 (dd,
8H, J ) 4.4), 9.15 (s, 4H), 8.49, 8.10 (d, 8H, J ) 8.1), 8.35 (s,
4H), 2.62 (s, 12H), 1.95 (s, 18H), -2.49 (s, 2H); MS (ESI) m/z
(MH+, 957).
5,10-Bis(3,5-d ia ceta m id o-4-p yr id yl)-15,20-bis(4-ter t-bu -
tylp h en yl)p or p h yr in (IV). 1H NMR (CDCl3) [500 MHz NMR,
50 °C] δ 8.98 (s, 2H), 8,95, 8.91 (dd, 4H, J ) 5.0 Hz), 8.89 (s,
2H), 8.77 (s, 2H), 7.90 (s, 2H), 8.17, 7.79 (d, 8H, J ) 7.5 Hz),
2.29 (s, 6H), 1.64 (s, 27H), -2.72 (s, 2H); 13C NMR (DMSO-d6)
δ 170.3, 150.9, 149.6, 138.6, 134.7,131.2∼132.6, 124.3, 121.5,
117.9, 115.8, 35.1, 31.9, 24.7; MS (ESI) m/z (MH+, 957).
5,10,15-Tr is(3,5-d ia cet a m id o-4-p yr id yl)-20-(4-ter t-b u -
tylp h en yl)p or p h yr in (V). 1H NMR (DMSO-d6) δ 10.51 (s,
6H), 8.81∼8.97 (m, 8H), 8.59 (s, 6H), 8.12, 7.77 (dd, 4H, J )
8.1), 2.16 (s, 18H), 1.51 (s, 18H), -3.10, (s, 2 H); 13C
NMR (DMSO-d6) δ 170.8, 153.5, 151.4, 150.1, 138.9, 135.2,
132.4∼132.5, 129.9, 129.2, 126.3, 124.7, 122.3, 119.2, 116.4,
35.7, 32.5, 25.4; MS (ESI) m/z (MH+, 1016).
1-Bu tyl-6-for m ylu r a cil (11). A solution of the butylacetal
10 (0.50 g, 2.07 mmol) in 20 mL of CH2Cl2 was cooled to -78
°C and treated with 1.6 mL of BBr3 and stirred for 2 h at that
temperature. The cold bath was removed and the solution was
allowed to reach room temperature. Saturated NaHCO3 (15
mL) was added until the pH reached 7-7.5. The organic layer
was removed and the aqueous layer was extracted with CH2-
Cl2. The extracts were combined and dried (with Na2SO4), and
the solvent was removed to afford 0.315 g of the aldehyde 11
as a white solid (87%), mp 146-147 °C. 1H NMR (CDCl3), δ
9.57 (s, 1H), 9.18 (br, s, 1H), 6.25 (s, 1H), 4.19 (t, 2H, J ) 7.3
Hz), 1.63-1.53, (m, 2H), 1.43-1.33, (m, 2H), 0.95, (t, 3H, J )
7.3 Hz); 13C NMR (CDCl3) δ 186.0, 162.6, 151.5, 147.6, 115.0,
44.5, 32.3, 20.5, 14.4; MS (ESI) m/z (M-H+, 195). Anal. Calcd
for C11H18N2O4: C, 55.09; H, 6.16; N, 14.28. Found: C, 55.49;
H, 6.13; N, 14.25.
5,10,15,20-Tet r a k is(1′-b u t yl-6′-u r a cyl)p or p h yr in a t o-
(Zn )(II) (XII). Pyrrole (69.5µL, 1.0 mmol), 1-butyl-6-formyl-
uracil (196 mg, 1.0 mmol) and zinc acetate (109.8 mg, 0.50
mmol) were added to a boiling mixture of acetic acid (7.5 mL)
and nitrobenzene (5.0 mL). The reaction mixture was refluxed
for 10 h while monitoring the yields spectroscopically, and then
taken to dryness under vacuum. The resulting solid was
purified by chromatography, eluting with ethyl acetate to
afford ∼5.1% 12. 1H NMR (DMSO-d6) δ 11.83 (br, s, 4H), 9.50
(m, 8H), 6.26 (s, 4H), 3.56∼3.08 (m, 8H), 1.10∼0.91 (m, 8H),
0.30∼0.08 (m, 8H), 0.00∼-0.60 (m, 12H); 13C NMR (CDCl3) δ
185.0, 163.4, 150.6, 142.3, 110.4, 41.9, 30.3, 20.9, 14.5; MS
(ESI) m/z (MH+, 1037 for ZnXII). Anal. Calcd for C52H52N12O8-
Zn: C, 60.15; H, 5.05; N, 16.18, for C52H52N12O8Zn with 1
H2O: C, 59.12; H, 5.16; N, 15.90. Found: C, 60.04; H, 5.24; N
15.92.
5,10,15,20-Tetr a k is(3,5-d ia ceta m id o-4-p yr id yl)p or p h y-
r in (VI). Pyrrole (69.5 µL, 1.0 mmol) and 2,6-diacetamido-4-
formylpyridine 7 (221 mg, 1.0 mmol) were added to boiling
propionic acid (10.0 mL). The reaction mixture was refluxed
for 2 h and then taken to dryness under vacuum. The resulting
solid was purified by chromatography on silica gel eluting with
ethanol/ethyl acetate (1:1) to yield 77.1 mg (29%) of VI. 1H
NMR (DMSO-d6) δ 10.52 (s, 8H), 8.99 (s, 8H), 8.60 (s, 8H),
2.16 (s, 24H), -3.10, (s, 2H); 13C NMR (DMSO-d6) δ170.7,
153.2, 150.1, 132.7, 119.4, 116.5, 25.4; MS (ESI) m/z (MH+,
1075). Anal. Calcd for [C56H50N16O8 plus 2 H2O] C, 60.45; H,
4.89; N, 20.16. Found: C, 60.92; H, 4.95; N, 20.01.
Dia ceta m id op yr id yl/ter t-bu tylp h en yl P or p h yr in s. 2,6-
diacetamido-4-formylpyridine 7 (2.763 g, 12.5 mmol) and 4-tert-
butylbenzaldehyde (1.63 g, 1.68 mL, 10.0 mmol) were added
to 450 mL of boiling propionic acid and then 1.56 mL (22.6
mmol) of pyrrole was added. The reaction mixture was refluxed
for 2 h at which time a 23.8% yield of the mixture of porphyrins
was detected spectroscopically. The solvent was removed under
vacuum, and the resulting solid was purified by chromatog-
raphy eluting with hexane (I), to chloroform (II), chloroform/
ethyl acetate (1:1) (III, IV), and ethyl acetate (V, VI) to get
the four porphyrins with two different motifs at the meso
positions. A second column using 10% v/v dioxane in chloro-
form is used to purify the fractions containing both III and
IV, and typically the tetrasubstituted derivatives are not
isolated as they can be made directly. Based on starting
Ur a cyl/ter t-Bu tylp h en yl P or p h yr in s. Pyrrole (0.83 mL,
12.0 mmol), 1-butyl-6-formyluracil (1.568 g, 8.0 mmol) and zinc
acetate (2.90 g, 13.2 mmol) were added to a boiling mixture of
acetic acid (90.0 mL) and nitrobenzene (60.0 mL). After 10 min.
4-tert-butylbenzaldehyde (0.652 g, 0.67 mL, 4.0 mmol) was
added to the reaction mixture and reflux continued for 10 h.
A 22.4% overall yield of the mixture of porphyrins was detected
spectroscopically in the reaction mixture. The solvent was
removed under vacuum. The resulting solid was purified by
chromatography using a solvent gradient (isolated yield, %
yield based on starting pyrrole): starting with hexane I (0.075
g, 2.37%), then chloroform VIII (0.225 g, 6.44%), then chloro-
form/ethyl acetate (1:1) IX (0.08 g, 2.21%), and X (0.10 g,
2.76%), and ethyl acetate XI (0.02 g, 0.51%), and XII (5 mg,
0.12%) to get the four uracyl/phenyl porphyrins. A second
column using a 15% v/v dioxane/chloroform solution as eluent
can be used to separate IX, X, and their rotameric forms. An
∼18%, 0.5 g, isolated yield is obtained for the collection of
porphyrins with relative yields of I, 15%; VIII, 45%; IX, 15%;
X, 20%; XI, 4%; XII, 1%. Typically the tetrasubstituted
derivatives are not isolated as they can be made directly.
5-(1′-Bu tyl-6′-u r a cyl)-10,15,20-tr is(4-ter t-bu tylp h en yl)-
1
p or p h yr in (VIII). H NMR (CDCl3) [500 MHz NMR] δ 9.11,
9.05 (dd, 4H, J ) 4.5 Hz), 8.92 (s, 4H), 8.81 (s, 1H), 8.12∼8.22,
7.81∼7.84 (m, 12H), 6.60 (s, 1H), 3.47 (t, 2H, J ) 8.0 Hz), 1.20
(m, 2H), 0.41(m, 2H), 0.08(t, 3H, J ) 7.5 Hz); 13C NMR (CDCl3)
δ 162.5, 156.9, 151.6, 151.7, 139.4, 135.1, 129.2∼132.6, 124.5,